The effort, sponsored by two therapeutics companies, is providing no-cost genetic testing and counseling for people with Duchenne who otherwise couldn't afford it.
Element Genomics' technology will increase UCB's pipeline, focusing on target discovery and interpretation in disease relevant systems.
The team showed that sequencing can diagnose ill babies faster, leading to better outcomes and saving money by reducing unnecessary treatments and procedures.
The Salt Lake City-based molecular diagnostics company completed a $7.1 million initial public offering on the Nasdaq in July.
The company plans to use the proceeds to repay loan and revolving credit facilities incurred to pay a portion of its 2017 acquisition of Euroimmun.
The companies will integrate Agilent's Seahorse XFe96/XFe24 Analyzers with BioTek's Cytation 1 Cell Imaging Multi-Mode Reader.
An international team of researchers reported that the coronavirus is similar to viruses found in horseshoe bats, a known reservoir of the SARS coronavirus.
As part of the collaboration, Ethos veterinarians will send canine urine samples to LexaGene for testing on its LX6 prototype pathogen detection instrument.
The firm also received approval from the Singapore Health Sciences Authority to market the Unyvero blood culture cartridges.
The grant money will be provided through the EC's Horizon 2020 European Innovation Council program and Bpifrance's innovation development programs.
An Icahn School of Medicine at Mount Sinai-led team further reported that RNA repeats could be used as biomarkers for immunotherapy.
With integrated data for thousands of TCGA tumors, teams explored cancer subtypes, searched for prognostic insights, began mapping immune cell interactions, and more.
The NIH has committed $2 million in FY19 for projects to build informatics tools that can be used to better understand the functions of understudied proteins.
The company attributed the revenue decline to ongoing changes in how it bills for its diagnostics.
The team integrated tumor barcoding, genome editing, and ultra-deep barcode sequencing to interrogate pairwise combinations of tumor suppressor alterations.
Through their partnership, Genomenon and Veritas Genetics hope to develop a new literature prioritization engine to bring down the cost of WGS interpretation.
The Klebsiella pneumoniae isolate was among one of the first such highly resistant strains reported to the CDC, which sequenced and analyzed it.
Bringing together more than 1,000 prostate cancer exomes, researchers uncovered almost 100 significantly mutated genes, including drivers mutated in a fraction of tumors.
The ctDNA assay will be used to select patients for Phase 3 of Five Prime's registrational trial investigating bemarituzumab in gastric cancer patients.
The firm is in the midst of evaluating its strategic options and has hired Raymond James to assist in the process, which could include the sale of the firm, it said.
The company's net loss climbed about 30 percent to $4.0 million for Q4 2017, and reached $19.4 million for the full year.
The decline matched the struggles of the broader stock market, though bright spots could be found with GenMark, Quidel, and NanoString all having good months.
Two studies have found that analyzing the timing of horizontal gene transfer events can help date microbial phylogenies.
Researchers associated with the Cancer Genome Atlas (TCGA) Research Network will publish more than 25 papers this week to discuss findings from the initiative.
Precipio received a preliminary grace period until Sept. 24, 2018 to regain compliance by meeting minimum bid stock-price requirements.
Researchers report using genotyping to tie together illegal ivory shipments and trace them back to a handful of cartels, the New York Times reports.
Researchers find that historical factors influence which genes are the most highly studied, the Atlantic reports.
The US National Science Foundation's new sexual harassment policy is to go into effect next month, according to Nature News.
In Nature this week: genomic ancestry analysis of Sardinians, current noncoding mutations in colorectal cancer, and more.